Major gene alterations include gene fusions of TMPRSS2 with ETS family genes [62], the amplification of MYC oncogene, the deletion and/or mutation of PTEN and TP53 tumor suppressors, and, in advanced PCa, the amplification and/or mutation of AR. The gene discussed is AR; the disease is posterior cortical atrophy.